Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China-Reference-Cited by-同舟云学术

Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China

Published:2024-06-20 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Zhao Houyu¹²^ORCID,Sun Yexiang³,Yao Xi⁴,Shen Peng³,Lin Hongbo³,Zhan Siyan²⁵⁶^ORCID

Affiliation:

1. School of Medicine, Chongqing University, Chongqing, Chiana

2. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China

3. Department of Data Center,Yinzhou District Center for Disease Control and Prevention, Ningbo, China

4. Department of Infection Control, Peking University First Hospital, Beijing, China

5. Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China

6. Center for Intelligent Public Health, Institute for Artificial Intelligence, Peking University, Beijing, China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2368823

Reference30 articles.

1. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study

2. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration

3. U.S. Food and Drug Administration. FDA updates warnings for fluoroquinolone antibiotics. 2016 [cited 2023 Dec 14]. Available from: https://www.fda.gov/news-events/press-announcements/fda-updates-warnings-fluoroquinolone-antibiotics

4. China Food and Drug Administration. Warning of adverse reactions of ciprofloxacin injection. 2003 [cited 2023 Dec 14]. Available from: https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20031223010101883.html

5. China Food and Drug Administration. Revision of the instructions for gatifloxacin. 2007 [cited 2023 Dec 14]. Available from: https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypshmshxdgg/20070123010101209.html